Mojo Max Fusion XXX Recall - Undeclared Sildenafil and Tadalafil

FDA classified a Class I recall for Mojo Max Fusion XXX capsules distributed by Max Nutrition Inc. after agency analysis detected undeclared active pharmaceutical ingredients sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule). The product was marketed without required FDA approval via NDA or ANDA. All lots with expiration 12/31/2027 are affected, totaling 125 boxes distributed nationwide.

Healthcare providers and consumers should be aware this product poses serious safety risks—undeclared sildenafil and tadalafil can interact with nitrates commonly prescribed for diabetes, hypertension, and heart disease, potentially causing life-threatening hypotension. Pharmacies, healthcare providers, and retailers should cease distribution and contact Max Nutrition Inc. to report any adverse events. Patients using this product should consult their healthcare provider immediately.